International Forum Against Afghan Drugs Opens in Moscow

In-depth Report:

MOSCOW — A forum entitled “Afghan Drug Production – A Challenge to the International Community” opens here on Wednesday. It will focus on stepping up the fight against drug trafficking from Afghanistan, which has grown dramatically in the recent years.

The forum will be attended by heads of anti-drug authorities and law enforcement agencies from various countries, Russian and foreign experts, representatives from such international organizations as the United Nations, the Collective Security Treaty Organization, NATO and the Shanghai Cooperation Organization.

The situation around drug production in Afghanistan has gained a catastrophic character. Some 100,000 people died globally from Afghan drugs in 2009 alone. In all, Afghan-made opiates have claimed one million human lives in the past decade, and 16 million more ruined their health.


Articles by: Global Research

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]